Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesClinical trial: intragastric acid control in patients who have Barrett's oesophagus-comparison of once- and twice-daily regimens of esomeprazole and lansoprazole
Alimentary Pharmacology and Therapeutics, 07/01/09
Spechler SJ et al. - Esomeprazole 40 mg is significantly more effective than lansoprazole 30 mg in controlling intragastric pH with Barrett's oesophagus.
Today in Esophagus...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Barretts esophagus with high-grade dysplasia and intramucosal adenocarcinoma
Expert Review of Gastroenterology & Hepatology, 10/13/09
Radiofrequency Ablation of Barrett's Esophagus
Journal of Gastrointestinal Surgery, 10/13/09
Celiac Disease and Eosinophilic Esophagitis: A True Association
Journal of Pediatric Gastroenterology and Nutrition, 10/20/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
The Lancet - Early Online Publication, 10/19/09
Novel agents for the treatment of adenocarcinoma of the pancreas
Expert Review of Anticancer Therapy, 10/22/09
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Sponsor
Article Search
Sponsor